Director Charles Faith L. sold ABEONA THERAPEUTICS INC. ($ABEO) shares once on the open market in the last 365 days, for a total of $62,878.51. His most recent sale occurred on July 9, 2025. Among 11,678 insiders, his sales rank 10,130th by amount, well below the average of $8.6 million over 6.4 transactions. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 26, 2026 | ABEONA THERAPEUTICS INC. | $ABEO | Charles Faith L. | Director | A | Common Stock | 37313 | $0.00 | 176,407.0000 | 65,780,650 | 26.83% | 0.06% |
| Nov. 17, 2025 | CNS Pharmaceuticals, Inc. | $CNSP | Charles Faith L. | Director | A | Option to purchase common stock | 1517 | $0.00 | 1,517.0000 | 620,290 | 9999.99% | 0.24% |
| July 9, 2025 | ABEONA THERAPEUTICS INC. | $ABEO | Charles Faith L. | Director | S | Common Stock | 10738 | $5.86 | 139,094.0000 | 41,048,206 | 7.17% | 0.03% |
| April 16, 2025 | CDT Equity Inc. | $CDT | Charles Faith L. | Director | A | Common Stock | 115194 | $0.87 | 165,238.0000 | 6,662,755 | 230.19% | 1.73% |
| March 30, 2025 | CDT Equity Inc. | $CDT | Charles Faith L. | Director | A | Common Stock | 46629 | $0.89 | 50,044.0000 | 6,662,755 | 1365.42% | 0.70% |
| Jan. 31, 2025 | ABEONA THERAPEUTICS INC. | $ABEO | Charles Faith L. | Director | A | Common Stock | 36101 | $0.00 | 149,832.0000 | 41,048,206 | 31.74% | 0.09% |
| Dec. 18, 2024 | CDT Equity Inc. | $CDT | Charles Faith L. | Director | A | Stock Option (Right to Buy) | 420000 | $0.07 | 420,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 18, 2024 | CDT Equity Inc. | $CDT | Charles Faith L. | Director | A | Common Stock | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 18, 2024 | CDT Equity Inc. | $CDT | Charles Faith L. | Director | A | Common Stock | 266594 | $0.09 | 341,594.0000 | 0 | 355.46% | 0.00% |
| Sept. 23, 2024 | AVENUE THERAPEUTICS, INC. | $ATXI | Charles Faith L. | Director | A | Employee stock option (right to buy) | 30000 | $0.00 | 30,000.0000 | 341,324 | 9999.99% | 8.79% |
| Aug. 26, 2024 | ABEONA THERAPEUTICS INC. | $ABEO | Charles Faith L. | Director | A | Common Stock | 11797 | $0.00 | 113,731.0000 | 21,380,476 | 11.57% | 0.06% |
| July 8, 2024 | ABEONA THERAPEUTICS INC. | $ABEO | Charles Faith L. | Director | A | Common Stock | 23611 | $0.00 | 101,934.0000 | 21,380,476 | 30.15% | 0.11% |
| April 26, 2024 | ABEONA THERAPEUTICS INC. | $ABEO | Charles Faith L. | Director | P | Common Stock | 7550 | $3.28 | 78,323.0000 | 21,380,476 | 10.67% | 0.04% |
| April 8, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Charles Faith L. | Director | A | Option to purchase common stock | 17500 | $0.00 | 47,315.0000 | 0 | 58.70% | 0.00% |
| April 8, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Charles Faith L. | Director | A | Restricted Stock Units | 17500 | $0.00 | 64,815.0000 | 0 | 36.99% | 0.00% |
| Dec. 1, 2023 | CDT Equity Inc. | $CDT | Charles Faith L. | Director | A | Stock Option (Right to Buy) | 65000 | $5.51 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | AVENUE THERAPEUTICS, INC. | $ATXI | Charles Faith L. | Director | A | Employee stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |